Company Info






  Home > Archived Webinars >

FDA-CMS Parallel Review Process: Reflection on the Pilot Program and Adapting to Expected Guidance



 
Our Price: $395.00

Product Code: WB-7204
Qty:

Product Info
 
About the Product
Includes 1 hour Windows Media Video File and PowerPoint presentations for immediate download.


One device has already received approval via the FDA CMS parallel review process, and as the extended pilot program is expected to expire in December 2015 manufacturers are curious as to what will happen next. Future steps of this program could include a regulatory focus on device classes as opposed to single devices, and expanding the parallel review mindset to earlier parts of regulatory processes like pre-submission programs which would certainly impact trial design and management. Optimizing parallel review is essential if manufacturers wish to gain full value from this innovative upcoming program, and clarifying program attributes will enable stronger decision making for clinical teams.


Speakers:
Rochelle Fink, MD, JD
FDA-CMS Liaison
FDA

Sandra Statz
Vice President, Clinical and Regulatory Affairs
Exact Sciences Corporation


Participants that will find this webinar most beneficial will be those involved in medical device companies. Job titles of attendees that will be most applicable for this session will be:

  • Clinical Research
  • Clinical Affairs
  • Clinical Operations
  • Regulatory Affairs


Share your knowledge of this product. Be the first to write a review »